[HTML][HTML] Sustained release drug delivery applications of polyurethanes

MB Lowinger, SE Barrett, F Zhang, RO Williams III - Pharmaceutics, 2018‏ - mdpi.com
Since their introduction over 50 years ago, polyurethanes have been applied to nearly every
industry. This review describes applications of polyurethanes to the development of modified …

Development of a 12-item short version of the HIV stigma scale

M Reinius, L Wettergren, M Wiklander… - Health and quality of life …, 2017‏ - Springer
Background Valid and reliable instruments for the measurement of enacted, anticipated and
internalised stigma in people living with HIV are crucial for map** trends in the prevalence …

The global HIV epidemic: What the pathologist needs to know

C Del Rio - Seminars in diagnostic pathology, 2017‏ - Elsevier
Abstract The World Health Organization estimates that at the end of 2015, approximately
36.7 million people were living with HIV worldwide. An estimated 0.8% of adults aged 15–49 …

Progress towards 2020 global HIV impact and treatment targets

MI Mahy, KM Sabin, A Feizzadeh… - Journal of the …, 2021‏ - Wiley Online Library
Introduction Over the past 20 years, the response to the HIV epidemic has achieved
remarkable results. These results have often been motivated by targets adopted by countries …

Virological suppression and clinical management in response to viremia in South African HIV treatment program: a multicenter cohort study

LE Hermans, S Carmona, M Nijhuis… - PLoS …, 2020‏ - journals.plos.org
Background Uptake of antiretroviral treatment (ART) is expanding rapidly in low-and middle-
income countries (LMIC). Monitoring of virological suppression is recommended at 6 months …

Beyond viral suppression: the quality of life of people living with HIV in Sweden

G Zeluf-Andersson, LE Eriksson, LN Schönnesson… - AIDS care, 2019‏ - Taylor & Francis
Sweden has one of the best HIV treatment outcomes in the world and an estimated 95% of
all diagnosed people living with HIV are virally suppressed, but the quality of life (QoL) is …

Virological failure and all-cause mortality in HIV-positive adults with low-level viremia during antiretroviral treatment

O Elvstam, P Medstrand, A Yilmaz, PE Isberg… - PloS one, 2017‏ - journals.plos.org
Objective Although most HIV-infected individuals achieve undetectable viremia during
antiretroviral therapy (ART), a subset have low-level viremia (LLV) of varying duration and …

CSF concentrations of soluble TREM2 as a marker of microglial activation in HIV-1 infection

M Gisslén, A Heslegrave, E Veleva… - Neurology …, 2018‏ - neurology.org
Objective To explore changes in CSF sTREM2 concentrations in the evolving course of HIV-
1 infection. Methods In this retrospective cross-sectional study, we measured concentrations …

The human immunodeficiency virus care continuum in China: 1985–2015

Y Ma, Z Dou, W Guo, Y Mao, F Zhang… - Clinical Infectious …, 2018‏ - academic.oup.com
Background Human immunodeficiency virus (HIV) care continuum attrition is a major global
public health challenge. Few studies have examined this problem in resource-limited …

Cohort profile: InfCareHIV, a prospective registry-based cohort study of people with diagnosed HIV in Sweden

C Carlander, J Brännström, F Månsson, O Elvstam… - BMJ open, 2023‏ - bmjopen.bmj.com
Purpose The Swedish InfCareHIV cohort was established in 2003 to ensure equal and
effective care of people living with HIV (PLHIV) and enable long-term follow-up. InfCareHIV …